Clinician and Patient Reporting of Symptomatic Adverse Events in Cancer Clinical Trials: Using CTCAE and PRO-CTCAE® to Provide Two Distinct and Complementary Perspectives

Minasian LM, O'Mara A, Mitchell SA

Patient Related Outcome Measures 2022, 13:249-258

Published Date: 8 December 2022